| Tissue factor: an essential mediator of hemostasis and trigger of thrombosis SP Grover, N Mackman Arteriosclerosis, thrombosis, and vascular biology 38 (4), 709-725, 2018 | 562 | 2018 |
| Inflammasome activation triggers blood clotting and host death through pyroptosis C Wu, W Lu, Y Zhang, G Zhang, X Shi, Y Hisada, SP Grover, X Zhang, L Li, ... Immunity 50 (6), 1401-1411. e4, 2019 | 286 | 2019 |
| Intrinsic pathway of coagulation and thrombosis: Insights from animal models SP Grover, N Mackman Arteriosclerosis, thrombosis, and vascular biology 39 (3), 331-338, 2019 | 208 | 2019 |
| Patients with COVID-19 have elevated levels of circulating extracellular vesicle tissue factor activity that is associated with severity and mortality—brief report A Rosell, S Havervall, F von Meijenfeldt, Y Hisada, K Aguilera, SP Grover, ... Arteriosclerosis, Thrombosis, and Vascular Biology 41 (2), 878-882, 2021 | 184 | 2021 |
| Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors Y Hisada, SP Grover, A Maqsood, R Houston, C Ay, DF Noubouossie, ... haematologica 105 (1), 218, 2020 | 131 | 2020 |
| TIE2‐expressing monocytes/macrophages regulate revascularization of the ischemic limb AS Patel, A Smith, S Nucera, D Biziato, P Saha, RQ Attia, J Humphries, ... EMBO molecular medicine 5 (6), 858-869, 2013 | 124 | 2013 |
| Expression of factor V by resident macrophages boosts host defense in the peritoneal cavity N Zhang, RS Czepielewski, NN Jarjour, EC Erlich, E Esaulova, ... Journal of Experimental Medicine 216 (6), 1291-1300, 2019 | 104 | 2019 |
| Magnetic Resonance T1 Relaxation Time of Venous Thrombus Is Determined by Iron Processing and Predicts Susceptibility to Lysis P Saha, ME Andia, B Modarai, U Blume, J Humphries, AS Patel, ... Circulation 128 (7), 729-736, 2013 | 88 | 2013 |
| Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application JA Diaz, P Saha, B Cooley, OR Palmer, SP Grover, N Mackman, ... Arteriosclerosis, thrombosis, and vascular biology 39 (3), 311-318, 2019 | 86 | 2019 |
| Roles of coagulation proteases and PARs (protease-activated receptors) in mouse models of inflammatory diseases JJ Posma, SP Grover, Y Hisada, AP Owens III, S Antoniak, HM Spronk, ... Arteriosclerosis, thrombosis, and vascular biology 39 (1), 13-24, 2019 | 85 | 2019 |
| Cancer therapy–associated thrombosis SP Grover, YM Hisada, RS Kasthuri, BN Reeves, N Mackman Arteriosclerosis, thrombosis, and vascular biology 41 (4), 1291-1305, 2021 | 79 | 2021 |
| Tissue factor in atherosclerosis and atherothrombosis SP Grover, N Mackman Atherosclerosis 307, 80-86, 2020 | 73 | 2020 |
| Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis ME Andia, P Saha, J Jenkins, B Modarai, AJ Wiethoff, A Phinikaridou, ... Arteriosclerosis, thrombosis, and vascular biology 34 (6), 1193-1198, 2014 | 66 | 2014 |
| Antiangiogenic therapy inhibits venous thrombus resolution CE Evans, SP Grover, J Humphries, P Saha, AP Patel, AS Patel, ... Arteriosclerosis, thrombosis, and vascular biology 34 (3), 565-570, 2014 | 58 | 2014 |
| Postsurgical inflammation as a causative mechanism of venous thromboembolism MA Albayati, SP Grover, P Saha, BA Lwaleed, B Modarai, A Smith Seminars in thrombosis and hemostasis, 615-620, 2015 | 56 | 2015 |
| Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles N Tawil, R Bassawon, B Meehan, A Nehme, L Montermini, T Gayden, ... Blood advances 5 (6), 1682-1694, 2021 | 54 | 2021 |
| Comparison of the coagulopathies associated with COVID‐19 and sepsis RA Campbell, Y Hisada, F Denorme, SP Grover, EG Bouck, EA Middleton, ... Research and practice in thrombosis and haemostasis 5 (4), e12525, 2021 | 51 | 2021 |
| Phosphodiesterase 5 Inhibition Limits Doxorubicin-induced Heart Failure by Attenuating Protein Kinase G Iα Oxidation O Prysyazhna, JR Burgoyne, J Scotcher, SP Grover, D Kass, P Eaton Journal of Biological Chemistry 291 (33), 17427-17436, 2016 | 51 | 2016 |
| Platelet signaling pathways and new inhibitors SP Grover, W Bergmeier, N Mackman Arteriosclerosis, thrombosis, and vascular biology 38 (4), e28-e35, 2018 | 47 | 2018 |
| Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer Y Hisada, KB Garratt, A Maqsood, SP Grover, T Kawano, BC Cooley, ... Blood Advances 5 (2), 487-495, 2021 | 41 | 2021 |
